In vivo administration of mycobacterial cord factor (trehalose 6,6'- dimycolate) can induce lung and liver granulomas and thymic atrophy in rabbits

Infection and Immunity

Volumn 68, Issue 6, 2000, Pages 3704-3709

  Hamasaki, Naoko ^a   Isowa, K O Ichi ^b   Kamada, Kohachi ^b   Terano, Yoshitake ^c   Matsumoto, Takayuki ^a   Arakawa, Tetsuo ^a   Kobayashi, Kazuo ^a   Yano, Ikuya ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Center of Japan Biological Chemistry   (Japan)

^c Toneyama Inst for TB Research   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CORD FACTOR;

ANIMAL TISSUE; ARTICLE; CELL MEDIATED CYTOTOXICITY; DELAYED HYPERSENSITIVITY; DRUG EFFECT; GRANULOMATOUS INFLAMMATION; HISTOPATHOLOGY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LIVER GRANULOMA; LUNG GRANULOMA; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; RABBIT; RISK BENEFIT ANALYSIS; THYMUS ATROPHY;

ANIMALS; APOPTOSIS; ATROPHY; BODY WEIGHT; CORD FACTORS; FEMALE; GLYCOLIPIDS; GRANULOMA; GRANULOMA, RESPIRATORY TRACT; LIPIDS; LIVER; LUNG; MYCOLIC ACIDS; RABBITS; SPLEEN; THYMUS GLAND; TREHALOSE;

EID: 0034119172     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.6.3704-3709.2000     Document Type: Article

References (23)

1. Bekierkunst, A., I. S. Levij, E. Yarkoni, E. Vilkas, A. Adam, and E. Lederer. 1969. Granuloma formation induced in mice by chemically defined mycobacterial fractions. J. Bacteriol. 100:95-102.
2. Bloch, H. 1950. Studies on the virulence of tubercle bacilli. Isolation and biological properties of a constituent of virulent organisms. J. Exp. Med. 91:197-219.
3. Converse, P. J., A. M. Dannenberg, Jr., J. E. Estep, K. Sugisaki, Y. Abe, B. H. Schofield, and M. L. M. Pitt. 1996. Cavitary tuberculosis produced in rabbits by aerosolized virulent tubercle bacilli. Infect. Immun. 64:4776-4787.
4. Dannenberg, A. M., Jr. 1991. Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis. Immunol. Today 12:228-233.
5. Dannenberg, A. M., Jr. 1993. Immunopathogenesis of pulmonary tuberculosis. Hosp. Pract. 15:51-58.
6. Dannenberg, A. M., Jr. 1994. Rabbit model of tuberculosis, p. 149-156. In B. R. Bloom (ed.), Tuberculosis: pathogenesis, protection, and control. ASM Press, Washington, D.C.
7. Fujiwara, N., J. Pan, K. Enomoto, Y. Terano, T. Honda, and I. Yano. 1999. Production and partial characterization of anti-cord factor (trehalose-6,6′-dimycolate) IgG antibody in rabbits recognizing mycolic acid subclass of Mycobacterium tuberculosis or Mycobacterium avium. FEMS Immunol. Med. Microbiol. 24:141-149.
8. Goren, M. B., O. Brokl, and B. C. Das. 1976. Sulfatides of Mycobacterium tuberculosis: the structure of the principal sulfatide (SL-1). Biochemistry 15:2728-2735.
9. Kakimura, M., K. Onoe, M. Okada, T. Kimura, K. Kato, H. Okuyama, K. Morikawa, and K. Yamamoto. 1981. Failure of C3H mice to develop lung granuloma after intravenous injection of BCG cell wall vaccine. Immunology 43:1-9.
10. 36-48-mycolic acid-containing glycolipids from Nocardia rubra. Infect. Immun. 54:869-875.
11. Kato, M. 1968. Studies of a biochemical lesion in experimental tuberculosis in mice. VIII. Structural and functional damage in mouse liver mitochondria under the toxic action of cord factor. Am. Rev. Respir. Dis. 98:260-269.
12. Lurie, M. B. 1932. The correlation between the histological changes and the fate of living tubercle bacilli in the organs of tuberculous rabbits. J. Exp. Med. 55:31-54.
13. Lurie, M. B. 1964. Resistance to tuberculosis: experimental studies in native and acquired defensive mechanisms. Harvard University Press, Cambridge, Mass.
14. Maeda, H., Y. Yamamura, and Y. Ogawa. 1977. Mycobacterial antigens relating to experimental pulmonary cavity formation. Am. Rev. Respir. Dis. 115:617-623.
15. Matsunaga, I., S. Oka, N. Fujiwara, and I. Yano. 1996. Relationship between induction of macrophage chemotactic factors and formation of granulomas caused by mycolyl glycolipids from Rhodococcus ruber (Nocardia rubra). J. Biochem. 120:663-670.
16. Myrvik, Q. N. 1982. Immunopathology of pulmonary tuberculosis. Adv. Exp. Med. Biol. 155:649-657.
17. Myrvik, Q. N., E. S. Leake, and K. Tenner-Racz. 1983. Interaction of mycobacteria with normal and immunologically activated alveolar macrophages. Adv. Exp. Med. Biol. 162:83-98.
18. Ozeki, Y., K. Kaneda, N. Fujiwara, M. Morimoto, S. Oka, and I. Yano. 1997. In vivo induction of apoptosis in the thymus by administration of mycobacterial cord factor (trehalose 6,6′-dimycolate). Infect. Immun. 65:1793-1799.
19. Ribi, E., D. L. Granger, K. C. Milner, K. Yamamoto, S. M. Strain, R. Parker, R. W. Smith, W. Brehmer, and I. Azuma. 1982. Induction of resistance to tuberculosis in mice with defined components of mycobacteria and with some unrelated materials. Immunology 46:297-305.
20. Tabata, T., K. Kaneda, H. Watanabe, T. Abo, and I. Yano. 1996. Kinetics of organ-associated natural killer cells and intermediate CD3 cells during pulmonary and hepatic granulomatous inflammation induced by mycobacterial cord factor. Microbiol. Immunol. 40:651-658.
21. Watanabe, K., R. Hasunuma, T. Horikoshi, H. Yamana, H. Maruyama, N. Fujiwara, Y. Kumazawa, and I. Yano. 1999. Induction of hypersensitivity to endotoxin lethality in mice by treatment with trehalose 6,6′-dimycolate but not with 2,3,6,6′-tetraacyl trehalose 2′-sulfate. J. Endotoxin Res. 5:23-30.
22. Yamamura, Y., H. Maeda, and Y. Ogawa. 1986. Experimental pulmonary cavity formation by mycobacterial components and synthetic adjuvants. Microbiol. Immunol. 30:1175-1187.
23. Yano, I., I. Tomiyasu, S. Kitabatake, and K. Kaneda. 1984. Granuloma forming activity of mycolic acid-containing glycolipids in Nocardia and related taxa. Acta Leprol. 2:341-349.